Catalyst Wire Dossier Catalyst Wire Dossier

Insulin U-500

insulin · Portal Diabetes, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Insulin U-500, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500 [Phase 1]

See pricing